Related Experiment Videos

Cytokine secretion in children with acute Mycoplasma pneumoniae infection and wheeze

Susanna Esposito1, Roberta Droghetti, Samantha Bosis

  • 1Pediatric Department I, University of Milan, Italy.

Pediatric Pulmonology
|July 12, 2002
PubMed

Insights

Children with wheezing and Mycoplasma pneumoniae infection show elevated Interleukin-5 (IL-5) levels. This specific cytokine profile may explain how M. pneumoniae causes wheeze symptoms.

Area of Science:

  • Pediatric Pulmonology
  • Immunology
  • Infectious Diseases

Background:

  • Wheezing is a common respiratory symptom in children.
  • Mycoplasma pneumoniae is a frequent cause of respiratory infections.
  • Cytokine dysregulation is implicated in the pathogenesis of wheezing.

Purpose of the Study:

  • To investigate cytokine secretion patterns in children with acute Mycoplasma pneumoniae infection and wheezing.
  • To compare cytokine levels between infected children with wheeze, infected children without wheeze, and healthy controls.

Main Methods:

  • Serum samples were collected from 25 children aged 2-14 with wheezing and 16 healthy controls.
  • Concentrations of Interleukin-2 (IL-2), Interferon-gamma (IFN-gamma), Interleukin-4 (IL-4), and Interleukin-5 (IL-5) were measured using ELISA.
  • Patients were categorized based on M. pneumoniae infection status and presence of wheezing.

Main Results:

  • Children with acute M. pneumoniae infection and wheezing exhibited significantly higher IL-5 levels compared to those without infection and wheeze.
  • Elevated IL-5 levels were also observed in children with M. pneumoniae infection and wheeze compared to those with asymptomatic infection.
  • No significant differences in IL-2, IFN-gamma, or IL-4 levels were found between groups.

Conclusions:

  • Children experiencing wheezing alongside acute M. pneumoniae infection display a distinct cytokine profile with elevated IL-5.
  • This heightened IL-5 response may play a crucial role in the development of wheeze-related symptoms caused by M. pneumoniae.
  • Understanding this immune response could inform novel therapeutic strategies for M. pneumoniae-associated wheezing.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...